Table 6.

Impact of Stage in Previously Untreated Patients

Stage	No.	Deaths, No.a	Median (95% CI), y		Log-Rank P Value
Clinical T category
1	68	29	NYR (5.3–∞)		<.001
2	131	61	9.7 (5.2–∞)
3	97	60	4.1 (2.6–6.6)
4	83	54	2.4 (1.5–5.1)
Pathological T category
1	103	47	7.7 (5.1–∞)		<.001
2	127	63	6.6 (4.3–∞)
3	63	42	2.6 (1.8–6.5)
4	79	50	3.7 (1.9–4.5)
Clinical N category
0	204	97	7.6 (5.7–∞)		.005
1	68	38	5.1 (2.1–∞)
2	98	63	2.8 (1.7–5.3)
3	6	4	2.3 (0.4–∞)
Pathological N category
0	128	52	9.4 (6.5–∞)		<.001
1	56	33	4.5 (2.3–7.7)
2	140	92	2.6 (1.8–3.8)
3	3	1	NYR (2.0–∞)
Clinical stage
I	27	10	NYR (5.9–∞)		<.001
II	55	22	NYR (4.2–∞)
III	81	40	7.7 (4.0–∞)
IV	158	102	2.9 (2.0–5.1)
Pathological stage
I	42	16	NYR (5.9–∞)		.01
II	39	17	7.8 (4.1–∞)
III	54	29	5.2 (2.9–7.7)
IV	186	112	3.7 (2.4–5.3)

Abbreviations: CI, confidence interval; NYR, not yet reached.

^aDeaths among patients in categories not shown are excluded.